Pharmacyclics Offers Result from Phase II Trial of Ibrutinib
April 08, 2013
from PR Newswire
Streetinsider.com Pre-Open Movers 04/08: (LUFK) (BCRX) (PCYC) Higher; (DCTH) (OMPI) (BYI) Lower
April 08, 2013
Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
April 08, 2013
from PR Newswire
The Wild Story Behind A Promising Experimental Cancer Drug
April 05, 2013
Today, Pharmacyclics is a $5.3B company, a value attributable largely to its promising lead compound, ibrutinib, currently in late clinical development for chronic lymphocytic leukemia (CLL) and mantle... Read More
from Forbes Real Time
Top Stocks: Pharmacyclics, United Therapeutics Corporation, the Medicines Company, Cubist Pharmaceuticals Inc
March 27, 2013
Stocks to Watch: Tata Motors Limited (ADR) (NYSE:TTM), Precision Drilling Corp, Pharmacyclics, Inc.(NASDAQ:PCYC),
March 26, 2013
Small Caps Setting Up to Take a Hit
March 26, 2013
News Buzz: Pharmacyclics, TRW Automotive Holdings Corp., Infoblox, MannKind Corporation
March 25, 2013
Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)
March 23, 2013
Top Losers of Friday (Tibco Software Inc, Arbor Realty Trust, Informatica Corporation, Pharmacyclics)
March 22, 2013
Hot Option Plays: Stocks Slump After Hours
March 21, 2013
Cusick’s Corner 03-21-2013 After Hours The market finished at its worst levels of the day but it held up well, even with the lack of new participants. While the dips were not aggressively bought,... Read More
from DailyMarkets.com
XBI, ISIS, PCYC, INCY: ETF Inflow Alert
March 20, 2013
Symbols mentioned in this story: XBI, ISIS, PCYC, INCY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category
ETFs
from ETF Channel
Notable Analyst Rating Changes 03/20: (WAC) (BBRY) (WAG) Upgraded; (YHOO) (ZNGA) (DE) Downgraded
March 20, 2013
Morgan Stanley Starts Pharmacyclics (PCYC) at Equalweight
March 20, 2013
Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)
March 14, 2013
Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope
March 13, 2013
from PR Newswire
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
March 12, 2013
Stocks Recap: Teva Pharmaceutical Industries Ltd, the Medicines Company, Pharmacyclics, ISIS Pharmaceuticals
March 12, 2013
Snatch PCYC Even Cheaper Than Its Secondary?
March 11, 2013
Looking back to 3 days ago, Pharmacyclics, Inc. (PCYC) priced a 2,200,000 share secondary stock offering at $94.20 per share. Read More
category
Stocks
from Market News Video
Pharmacyclics (PCYC) Prices 2.2M Stock Offering
March 08, 2013
Pharmacyclics, Inc. Prices Public Offering of Common Stock
March 08, 2013
from PR Newswire
Pharmacyclics (PCYC) Moves Lower on 2.2M Stock Offering
March 07, 2013
Pharmacyclics (PCYC) Announces 2.2M Common Stock Offering
March 07, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here